首页> 外文期刊>Gut and Liver >Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract
【24h】

Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract

机译:预防非甾体抗炎药的潜在策略 - 较低胃肠道中的非甾体抗炎药相关不良反应

获取原文
           

摘要

With the increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), the incidence of lower gastrointestinal (GI) complications is expected to increase. However, unlike upper GI complications, the burden, pathogenesis, prevention and treatment of NSAID-associated lower GI complications remain unclear. To date, no cost-effective and safe protective agent has been developed that can completely prevent or treat NSAID-related lower GI injuries. Selective COX-2 inhibitors, misoprostol, intestinal microbiota modulation, and some mucoprotective agents have been reported to show protective effects on NSAID-induced lower GI injuries. This review aims to provide an overview of the current evidence on the prevention of NSAID-related lower GI injuries.
机译:随着非甾体抗炎药(NSAIDS)的越来越多,预计胃肠道(GI)并发症的发病率会增加。然而,与上GI并发症不同,NSAID相关较低GI并发症的负担,发病机制,预防和治疗仍不清楚。迄今为止,没有开发任何具有成本效益和安全的防护剂,可以完全预防或治疗NSAID相关的较低的GI损伤。据报道,选择性COX-2抑制剂,误狂醇,肠道微生物脂蛋白调节和一些粘膜或一些粘膜或一些粘液保护剂表明对NSAID诱导的较低GI损伤的保护作用。该审查旨在概述目前预防NSAID相关的较低GI伤害的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号